Home LiteratureArticle Details
PMID: 17548478 Published · ppublish English Journal Article Validation Study

Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus.

Infection and immunity ·Vol. 75 ·No. 9 ·2007-09-00 ·Pages 4519-27

Shaw LN, Jonsson IM, Singh VK, Tarkowski A, Stewart GC

Abstract

The success of Staphylococcus aureus as a pathogen can largely be attributed to the plethora of genetic regulators encoded within its genome that temporally regulate its arsenal of virulence determinants throughout its virulence lifestyle. Arguably the most important of these is the two-component, quorum-sensing system agr. Over the last decade, the controversial presence of a second quorum-sensing system (the TRAP system) has been proposed, and it has been mooted to function as the master regulator of virulence in S. aureus by modulating agr. Mutants defective in TRAP are reported to be devoid of agr expression, lacking in hemolytic activity, essentially deficient in the secretion of virulence determinants, and avirulent in infection models. A number of research groups have questioned the validity of the TRAP findings in recent years; however, a thorough and independent analysis of its role in S. aureus physiology and pathogenesis has not been forthcoming. Therefore, we have undertaken such an analysis of the TRAP locus of S. aureus. We found that a traP mutant was equally hemolytic as the wild-type strain. Furthermore, transcriptional profiling found no alterations in the traP mutant in expression levels of agr or in expression levels of multiple agr-regulated genes (hla, sspA, and spa). Analysis of secreted and surface proteins of the traP mutant revealed no deviation in comparison to the parent. Finally, analysis conducted using a murine model of S. aureus septic arthritis revealed that, in contrast to an agr mutant, the traP mutant was just as virulent as the wild-type strain.

MeSH Terms
Animals Arthritis, Infectious/genetics,metabolism,microbiology Bacterial Proteins/genetics,physiology Disease Models, Animal Female Gene Expression Regulation, Bacterial/physiology Gene Silencing Hemolysis/genetics Mice Quorum Sensing/genetics,physiology RNA-Binding Proteins/genetics Staphylococcal Infections/genetics,metabolism,microbiology Staphylococcus aureus/genetics,pathogenicity Trans-Activators/genetics,physiology Transcription Factors/deficiency,genetics Virulence
Chemicals
Agr protein, Staphylococcus aureus Bacterial Proteins MtrB protein, Bacteria RNA-Binding Proteins Trans-Activators Transcription Factors
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Shaw Lindsey N
Department of Veterinary Pathobiology, University of Missouri, Columbia, MO 65211, USA.
Jonsson Ing-Marie
Singh Vineet K
Tarkowski Andrej
Stewart George C
References (69)
69 references, click to expand
  1. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Peptides. 2005 Feb;26(2):169-75 PMID: 15629527
  2. Transient interference with staphylococcal quorum sensing blocks abscess formation.
    Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1691-6 PMID: 15665088
  3. Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype.
    J Bacteriol. 2005 Mar;187(5):1751-62 PMID: 15716447
  4. Identification of the putative staphylococcal AgrB catalytic residues involving the proteolytic cleavage of AgrD to generate autoinducing peptide.
    J Biol Chem. 2005 Apr 29;280(17):16695-704 PMID: 15734745
  5. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP.
    Clin Orthop Relat Res. 2005 Aug;(437):48-54 PMID: 16056025
  6. Transcriptional profiling of target of RNAIII-activating protein, a master regulator of staphylococcal virulence.
    Infect Immun. 2005 Oct;73(10):6220-8 PMID: 16177293
  7. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    J Infect Dis. 2006 Jan 15;193(2):180-6 PMID: 16362881
  8. A slipped-mispairing mutation in AgrA of laboratory strains and clinical isolates results in delayed activation of agr and failure to translate delta- and alpha-haemolysins.
    Mol Microbiol. 2006 Mar;59(5):1519-30 PMID: 16468992
  9. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Shock. 2006 Sep;26(3):296-301 PMID: 16912656
  10. Investigations into sigmaB-modulated regulatory pathways governing extracellular virulence determinant production in Staphylococcus aureus.
    J Bacteriol. 2006 Sep;188(17):6070-80 PMID: 16923874
  11. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.
    Antimicrob Agents Chemother. 2007 Jun;51(6):2226-9 PMID: 17371825
  12. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.
    Antimicrob Agents Chemother. 2007 Jul;51(7):2594-6 PMID: 17116671
  13. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus.
    J Infect Dis. 2000 Dec;182(6):1688-93 PMID: 11069241
  14. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP.
    Peptides. 2000 Sep;21(9):1301-11 PMID: 11072116
  15. Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus.
    J Bacteriol. 2001 Feb;183(4):1113-23 PMID: 11157922
  16. Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach.
    FEMS Microbiol Lett. 2001 May 15;199(1):79-84 PMID: 11356571
  17. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating Protein (TRAP).
    J Biol Chem. 2001 Jan 26;276(4):2658-67 PMID: 11160124
  18. Regulation of virulence determinants in Staphylococcus aureus.
    Int J Med Microbiol. 2001 May;291(2):159-70 PMID: 11437338
  19. The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus.
    Mol Microbiol. 2001 Jul;41(1):247-61 PMID: 11454217
  20. Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease.
    J Biol Chem. 2001 Aug 10;276(32):29969-78 PMID: 11399757
  21. RNAIII inhibiting peptide (RIP) inhibits agr-regulated toxin production.
    Peptides. 2001 Oct;22(10):1621-7 PMID: 11587790
  22. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci.
    J Bacteriol. 2001 Dec;183(24):7341-53 PMID: 11717293
  23. In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence.
    J Bacteriol. 2002 Mar;184(5):1430-7 PMID: 11844774
  24. Global regulation of virulence determinants in Staphylococcus aureus by the SarA protein family.
    Front Biosci. 2002 Aug 1;7:d1825-42 PMID: 12133812
  25. sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4.
    J Bacteriol. 2002 Oct;184(19):5457-67 PMID: 12218034
  26. Transmembrane topology of AgrB, the protein involved in the post-translational modification of AgrD in Staphylococcus aureus.
    J Biol Chem. 2002 Sep 20;277(38):34736-42 PMID: 12122003
  27. Current status of pathogenetic mechanisms in staphylococcal arthritis.
    FEMS Microbiol Lett. 2002 Dec 17;217(2):125-32 PMID: 12480095
  28. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
    J Infect Dis. 2003 Feb 15;187(4):625-30 PMID: 12599079
  29. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2003 Jun;47(6):1979-83 PMID: 12760879
  30. Autoinduction and signal transduction in the regulation of staphylococcal virulence.
    Mol Microbiol. 2003 Jun;48(6):1429-49 PMID: 12791129
  31. Characterization of RAP, a quorum sensing activator of Staphylococcus aureus.
    FEMS Microbiol Lett. 2003 Jun 27;223(2):167-75 PMID: 12829282
  32. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
    Circulation. 2003 Aug 12;108(6):767-71 PMID: 12885754
  33. The role and regulation of the extracellular proteases of Staphylococcus aureus.
    Microbiology. 2004 Jan;150(Pt 1):217-28 PMID: 14702415
  34. Inhibition of Staphylococcus aureus pathogenesis in vitro and in vivo by RAP-binding peptides.
    Peptides. 2003 Nov;24(11):1823-8 PMID: 15019215
  35. Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in acquired Staphylococcus aureus sepsis: a histopathological assessment.
    Peptides. 2003 Nov;24(11):1829-36 PMID: 15019216
  36. Quorum sensing in Staphylococci is regulated via phosphorylation of three conserved histidine residues.
    J Biol Chem. 2004 Apr 9;279(15):14665-72 PMID: 14726534
  37. Membrane anchoring of the AgrD N-terminal amphipathic region is required for its processing to produce a quorum-sensing pheromone in Staphylococcus aureus.
    J Biol Chem. 2004 May 7;279(19):19448-56 PMID: 15001569
  38. Microarray-based analysis of the Staphylococcus aureus sigmaB regulon.
    J Bacteriol. 2004 Jul;186(13):4085-99 PMID: 15205410
  39. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
    J Infect Dis. 2004 Jul 15;190(2):318-20 PMID: 15216467
  40. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo.
    J Infect Dis. 2004 Oct 15;190(8):1498-505 PMID: 15378444
  41. The influence of agr and sigmaB in growth phase dependent regulation of virulence factors in Staphylococcus aureus.
    Proteomics. 2004 Oct;4(10):3034-47 PMID: 15378746
  42. Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus.
    J Bacteriol. 1988 Sep;170(9):4365-72 PMID: 2457579
  43. Identification and nucleotide sequence of the delta-lysin gene, hld, adjacent to the accessory gene regulator (agr) of Staphylococcus aureus.
    Mol Gen Genet. 1989 Nov;219(3):480-5 PMID: 2622452
  44. The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus.
    EMBO J. 1990 May;9(5):1391-9 PMID: 2328718
  45. A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus.
    J Bacteriol. 1991 Oct;173(20):6313-20 PMID: 1717437
  46. Regulation of the protein A-encoding gene in Staphylococcus aureus.
    Gene. 1992 May 1;114(1):25-34 PMID: 1587482
  47. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr.
    Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6462-6 PMID: 1321441
  48. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model.
    Infect Immun. 1993 Sep;61(9):3879-85 PMID: 8359909
  49. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.
    EMBO J. 1993 Oct;12(10):3967-75 PMID: 7691599
  50. Regulation of alpha- and beta-hemolysins by the sar locus of Staphylococcus aureus.
    J Bacteriol. 1994 Feb;176(3):580-5 PMID: 7507919
  51. Characterization of a Tn551-mutant of Staphylococcus aureus defective in the production of several exoproteins.
    Can J Microbiol. 1994 Aug;40(8):677-81 PMID: 7922890
  52. Autocrine regulation of toxin synthesis by Staphylococcus aureus.
    Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1619-23 PMID: 7533297
  53. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus.
    Mol Gen Genet. 1995 Aug 30;248(4):446-58 PMID: 7565609
  54. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone.
    Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12055-9 PMID: 8618843
  55. Detection of the response regulator AgrA in the cytosolic fraction of Staphylococcus aureus by monoclonal antibodies.
    FEMS Microbiol Lett. 1996 Oct 1;143(2-3):195-201 PMID: 8837472
  56. Bacterial interference caused by autoinducing peptide variants.
    Science. 1997 Jun 27;276(5321):2027-30 PMID: 9197262
  57. Alternative transcription factor sigmaSB of Staphylococcus aureus: characterization and role in transcription of the global regulatory locus sar.
    J Bacteriol. 1997 Oct;179(20):6355-9 PMID: 9335283
  58. Structure of the pheromone peptide of the Staphylococcus epidermidis agr system.
    FEBS Lett. 1998 Mar 6;424(1-2):89-94 PMID: 9537521
  59. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.
    Science. 1998 Apr 17;280(5362):438-40 PMID: 9545222
  60. Genetic instability of the global regulator agr explains the phenotype of the xpr mutation in Staphylococcus aureus KSI9051.
    J Bacteriol. 1998 May;180(10):2609-15 PMID: 9573143
  61. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus.
    Mol Microbiol. 1998 May;28(3):655-62 PMID: 9632266
  62. Staphylococcus aureus infections.
    N Engl J Med. 1998 Aug 20;339(8):520-32 PMID: 9709046
  63. The role of environmental factors in the regulation of virulence-determinant expression in Staphylococcus aureus 8325-4.
    Microbiology. 1998 Sep;144 ( Pt 9):2469-79 PMID: 9782494
  64. Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus.
    J Bacteriol. 1998 Dec;180(23):6232-41 PMID: 9829932
  65. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence.
    Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1218-23 PMID: 9990004
  66. Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus.
    Mol Gen Genet. 1999 Sep;262(2):323-31 PMID: 10517329
  67. Staphylococcal coagulase; mode of action and antigenicity.
    J Gen Microbiol. 1952 Feb;6(1-2):95-107 PMID: 14927856
  68. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci.
    Peptides. 2004 Dec;25(12):2047-53 PMID: 15572191
  69. Quorum-sensing control in Staphylococci -- a target for antimicrobial drug therapy?
    FEMS Microbiol Lett. 2004 Dec 15;241(2):135-41 PMID: 15598524
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2007-09-00
Epub
2007-00-04
Pages
4519-27
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC1951194
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com